diff --git a/knowledge/large_corpus.xbel.gz b/knowledge/large_corpus.xbel.gz
index 010e858..12e0116 100644
Binary files a/knowledge/large_corpus.xbel.gz and b/knowledge/large_corpus.xbel.gz differ
diff --git a/knowledge/small_corpus.xbel b/knowledge/small_corpus.xbel
index 51077cf..b6f2f84 100644
--- a/knowledge/small_corpus.xbel
+++ b/knowledge/small_corpus.xbel
@@ -2958,8 +2958,8 @@ complex (Figure 3 and Box 1).
HIF1A
- P
H
+ P
@@ -9747,43 +9747,6 @@ in the catalytic domains of C-Raf, wild-type B-Raf, and V599EB-Raf mutant.
"Group 5"
-
-
- Review
-
- 12444918
- The Biochemical journal
-
-
- Houslay MD
- Adams DR
-
-
- Originally identified by high-throughput screening of small molecules against C-Raf
-kinase, sorafenib was found to be a potent competitive inhibitor of ATP binding
-in the catalytic domains of C-Raf, wild-type B-Raf, and V599EB-Raf mutant.
-
-
-
-
- ADRB2
-
-
-
-
-
-
- ADRB2
-
-
- PDE4 Family
-
-
- ARRB Family
-
-
-
-
Review